Clearside BiomedicalCLSDQ
13F holders, Q3 2025 (September 30)24holders
1famous investor
$3.97avg. 13F price*
At the end of Q3 2025, 24 institutions reported holding Clearside Biomedical Inc. (CLSDQ) in their 13F filings. The largest holders were Vanguard Group Inc. ($881K), Geode Capital Management, LLC ($209K) and BlackRock, Inc. ($165K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Clearside Biomedical Inc.
- CUSIP
- 185063203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $59K |
| Exits | 0 | $0 |
Ownership 24 holders
| Vanguard Group Inc. | 0.00% | Reduce -1.0% | 221,968 | $881K |
| Geode Capital Management, LLC | 0.00% | No change | 52,741 | $209K |
| BlackRock, Inc. | 0.00% | No change | 41,677 | $165K |
| Renaissance Technologies | 0.00% | Reduce -23.7% | 25,247 | $100K |
| First Manhattan Co. Llc. | 0.00% | No change | 22,846 | $91K |
| State Street Corp. | 0.00% | Reduce -7.3% | 16,387 | $65K |
| Gsa Capital Partners LLP | 0.00% | Reduce -63.8% | 12,885 | $51K |
| Apollon Wealth Management, LLC | 0.00% | New | 11,793 | $47K |
| Northern Trust Corp. | 0.00% | No change | 11,032 | $44K |
| UBS Group AG | 0.00% | Add +329.2% | 9,303 | $37K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 7,194 | $29K |
| New Millennium Group LLC | 0.01% | New | 2,952 | $12K |
| Morgan Stanley | 0.00% | Reduce -91.4% | 750 | $3K |
| Wells Fargo & Company | 0.00% | No change | 400 | $2K |
| Bank of America Corp. | 0.00% | Reduce -18.3% | 118 | $469 |
| FMR LLC | 0.00% | New | 83 | $330 |
| CIBC Private Wealth Group LLC | 0.00% | Reduce -0.5% | 73 | $290 |
| Financial Consulate, Inc. | 0.00% | New | 66 | $263 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -2.2% | 51 | $202 |
| JPMorgan Chase & Co. | 0.00% | Reduce -17.9% | 46 | $183 |
| Barclays PLC | 0.00% | New | 14 | $56 |
| Creative Financial Designs Inc. | 0.00% | Reduce -10.0% | 6 | $24 |
| Allworth Financial LP | 0.00% | Reduce -10.0% | 3 | $12 |
| Citigroup Inc. | 0.00% | New | 1 | $4 |
"% of holder's portfolio" is CLSDQ's weight in each manager's 13F, not the share of Clearside Biomedical Inc. the manager owns.